Increased IGF/IGF-1R signaling promotes sorafenib resistance through increasing the cancer stemness of cancer cells, upregulating the microRNAs, which regulate IGF/IGF1R signaling, or inducing in IGFBPs production. This evidence concerns the gene IGF1R and cancer.